CN102552404A - Antipyretic - Google Patents
Antipyretic Download PDFInfo
- Publication number
- CN102552404A CN102552404A CN2011104514231A CN201110451423A CN102552404A CN 102552404 A CN102552404 A CN 102552404A CN 2011104514231 A CN2011104514231 A CN 2011104514231A CN 201110451423 A CN201110451423 A CN 201110451423A CN 102552404 A CN102552404 A CN 102552404A
- Authority
- CN
- China
- Prior art keywords
- antipyretic
- parts
- present
- liver
- radix bupleuri
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
An antipyretic comprises radix bupleuri, cassia twig, sweet wormwood, mint, and liquorice. The antipyretic provided by the invention is prepared from traditional Chinese medicine components, and liquorice is used for enhancing detoxification function of liver, thereby the antipyretic has no side effects, cannot cause harm to liver, can kill virus basically, and has no recurrence.
Description
Technical field
The present invention relates to medicine, especially a kind of antipyretic.
Technical background
Heating is modal clinical symptoms, and persistent fever possibly cause that regulatory function is disorderly in the body, causes a series of other symptoms; At present, the medicine of bringing down a fever all is a Western medicine, and these medicines often can only temporarily be brought down a fever; Can not fundamentally treat; Therefore easy relapse often after bringing down a fever if take or take for a long time these medicines in a large number, can cause very big infringement to patient's liver.
Summary of the invention
The technical problem that the present invention mainly solves provides a kind of antipyretic, can fundamentally effectively treat fever, and have no side effect.
For solving the problems of the technologies described above, the technical scheme that the present invention adopts is: a kind of antipyretic comprises Radix Bupleuri, Ramulus Cinnamomi, Artemisia annua L., Herba Menthae, Radix Glycyrrhizae.
In preferred embodiment of the present invention, said Radix Bupleuri 40-80 part, Ramulus Cinnamomi 20-30 part, Artemisia annua L. 10-30 part, Herba Menthae 2-4 part, Radix Glycyrrhizae 2-4 part.
In preferred embodiment of the present invention, 60 parts of said Radix Bupleuri, 25 parts of Ramulus Cinnamomi, 3 parts of 20 portions of Herba Menthaes of Artemisia annua L., 3 parts in Radix Glycyrrhizae.
After implementing above technical measures, have following technique effect:
1. the present invention fundamentally brings down a fever effectively, prevents disease relapse.
2. the present invention has no side effect, and can not cause damage to liver.
The specific embodiment
Set forth in detail in the face of preferred embodiment of the present invention down, thereby protection scope of the present invention is made more explicit defining so that advantage of the present invention and characteristic can be easier to it will be appreciated by those skilled in the art that.
The embodiment of the invention comprises:
Radix Bupleuri: analgesic, detoxifcation promotes immunologic function, and heating due to typhoid fever, paratyphoid fever vaccine, escherichia coli liquid, fermented milk, the yeast etc. is had the trivial solution heat effect; And the animal normal body temperature is descended, can phagocytic function strengthen, the natural killer cell increased functionality, improve the special viral antibody titre, improve lymphocyte and change the nuclear rate, improve the skin delayed hypersensitivity reaction, and can effectively prevent hepar damnification.
Ramulus Cinnamomi: can blood vessel dilating, regulate blood circulation, make blood flow to body surface, strengthen perspiration, promote diaphoresis, antibiotic, antiviral, to staphylococcus aureus, Bacillus typhi, pathogenic fungus, influenza virus, Orphan virus effect are especially obvious.
Herba Artemisiae Annuae: staphylococcus epidermidis, micrococcus catarrhalis, anthrax bacillus, diphtheria corynebacterium are had stronger bacteriostasis, staphylococcus aureus, bacillus pyocyaneus, dysentery bacterium, tuberculosis stalk bacterium etc. are also had certain inhibitory action.
Radix Glycyrrhizae: have Detoxication, the glycyrrhizin in the Radix Glycyrrhizae has adsorption to poisonous substance, and glycyrrhizin hydrolyzate glucuronic acid can combine with poisonous substance, and GLYCYRRHIN have the effect of adrenocortical hormone appearance, the detoxification ability of enhancing liver.
Herba Menthae: have the effect that stimulates nervus centralis; Act on skin and the sense of burning and creeping chill are arranged simultaneously; It has again sensory nerve ending and suppresses and the effect of paralysis, and tangible relieving ease pain, and upper respiratory tract infection is also had tangible cough-relieving, antiinflammatory and bacteriostasis.
Embodiment 1:
A kind of antipyretic fully mixes 40 parts of Radix Bupleuri, 20 parts of Ramulus Cinnamomi, 10 parts of Artemisia annua L., Herba Menthae 2-4 part, Radix Glycyrrhizae 2-4 part, after the grinding, processes graininess.
Embodiment 2:
A kind of antipyretic fully mixes 60 parts of Radix Bupleuri, 25 parts of Ramulus Cinnamomi, 20 parts of Artemisia annua L., 3 parts of Herba Menthaes, Radix Glycyrrhizae for 3 parts, after the grinding, processes graininess.
Embodiment 3:
A kind of antipyretic fully mixes 80 parts of Radix Bupleuri, 30 parts of Ramulus Cinnamomi, 30 parts of Artemisia annua L., 4 parts of Herba Menthaes, Radix Glycyrrhizae for 4 parts, after the grinding, processes graininess.
Because medicine of the present invention all adopts Chinese medicine ingredients to process, and strengthens the functions of expelling toxin of liver through Radix Glycyrrhizae, so have no side effect, can not cause damage to liver, medicine of the present invention is elimination virus fundamentally, therefore can not recur.
The above is merely embodiments of the invention; Be not so limit claim of the present invention; Every equivalent structure or equivalent flow process conversion that utilizes description of the present invention to do; Or directly or indirectly be used in other relevant technical fields, all in like manner be included in the scope of patent protection of the present invention.
Claims (3)
1. an antipyretic is characterized in that, comprises Radix Bupleuri, Ramulus Cinnamomi, Artemisia annua L., Herba Menthae, Radix Glycyrrhizae.
2. antipyretic according to claim 1 is characterized in that, said Radix Bupleuri 40-80 part, Ramulus Cinnamomi 20-30 part, Artemisia annua L. 10-30 part, Herba Menthae 2-4 part, Radix Glycyrrhizae 2-4 part.
3. antipyretic according to claim 1 is characterized in that, 60 parts of said Radix Bupleuri, 25 parts of Ramulus Cinnamomi, 3 parts of 20 portions of Herba Menthaes of Artemisia annua L., 3 parts in Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104514231A CN102552404A (en) | 2011-12-30 | 2011-12-30 | Antipyretic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104514231A CN102552404A (en) | 2011-12-30 | 2011-12-30 | Antipyretic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102552404A true CN102552404A (en) | 2012-07-11 |
Family
ID=46399860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104514231A Pending CN102552404A (en) | 2011-12-30 | 2011-12-30 | Antipyretic |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102552404A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189609A (en) * | 2014-09-19 | 2014-12-10 | 商丘爱己爱牧动物药业有限公司 | Veterinary Chinese herbal medicine compound preparation for relieving fever |
| CN105560547A (en) * | 2016-01-21 | 2016-05-11 | 广东省人民医院 | Traditional Chinese medicine composition for treating exogenous fever |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1511553A (en) * | 2002-12-30 | 2004-07-14 | 龙 代 | Infantile antipyretic |
-
2011
- 2011-12-30 CN CN2011104514231A patent/CN102552404A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1511553A (en) * | 2002-12-30 | 2004-07-14 | 龙 代 | Infantile antipyretic |
Non-Patent Citations (2)
| Title |
|---|
| 吴银根: "温病治法在SARS与呼吸疾病中应用体会", 《第七次全国中西医结合呼吸病学术交流大会论文汇编2》 * |
| 黄煌: "实习日记三则", 《江苏医药》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189609A (en) * | 2014-09-19 | 2014-12-10 | 商丘爱己爱牧动物药业有限公司 | Veterinary Chinese herbal medicine compound preparation for relieving fever |
| CN104189609B (en) * | 2014-09-19 | 2017-05-17 | 商丘爱己爱牧生物科技股份有限公司 | Veterinary Chinese herbal medicine compound preparation for relieving fever |
| CN105560547A (en) * | 2016-01-21 | 2016-05-11 | 广东省人民医院 | Traditional Chinese medicine composition for treating exogenous fever |
| CN105560547B (en) * | 2016-01-21 | 2020-03-27 | 广东省人民医院 | Traditional Chinese medicine composition for treating exogenous fever |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102552404A (en) | Antipyretic | |
| CN102600442B (en) | Chinese medicinal composition for treating bovine influenza due to wind cold, and application thereof | |
| CN104069454A (en) | Traditional Chinese medicine for treating epilepsy | |
| CN103157067A (en) | Traditional Chinese medicine preparation for treating trigeminal neuralgia | |
| CN104435126B (en) | Traditional Chinese medicine preparation for improving rheumatic arthralgia and resisting fatigue and preparation method thereof | |
| CN103007027A (en) | Pill for treating migraine | |
| CN102552533B (en) | Chinese medicinal formula for treating diabetes | |
| CN104524047A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN103142709A (en) | Medicament for treating cold | |
| CN106177852A (en) | One is used for treating beriberic Chinese medicine | |
| CN101249250A (en) | Medicinal liquor preparations for curing stagnation and blood stasis chest stuffiness and pain | |
| CN105664079A (en) | Medicine for treating pneumonia | |
| CN106581244A (en) | Chinese medicinal formula for treatment of tinea pedis | |
| CN105664080A (en) | Medicine for treating influenza | |
| CN103638093A (en) | Medicine for treating chronic pharyngitis | |
| CN102648958B (en) | Traditional Chinese medicine enema for treating acute upper respiratory infections of children | |
| CN103479790A (en) | Proved prescription used for treating influenza | |
| CN103800830A (en) | Traditional Chinese medicine composition for treating hepatitis | |
| CN106491723A (en) | A kind of Traditional chinese medicine medicament foot bath formula for treating anemopyretic cold | |
| CN105497392A (en) | Traditional Chinese medicine formula for treating dyspepsia in the type of liver-stomach disharmony | |
| CN103479721A (en) | Proved prescription used for treating influenza | |
| CN102824609A (en) | Medicine for treating gynecological inflammation and preparation method thereof | |
| CN106539880A (en) | A kind of Traditional chinese medicine medicament foot bath formula for treating anemopyretic cold | |
| 李有田 et al. | Shugan Jieyu Yin for treatment of senile depression—a clinical report of 84 cases | |
| CN107661459A (en) | One kind treats phthisical Chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120711 |
|
| WD01 | Invention patent application deemed withdrawn after publication |